Introduction
============

The Codon Adaptation Index (CAI) measures the synonymous codon, using bias for DNA or RNA sequence. CAI has known to be an excellent predictor of gene expression in prokaryotes and unicellular eukaryotes. CAI has evaluated the effect of natural selection in pattern of codon usage, and prediction of gene expression level \[[@b1-IJCP-06-214], [@b2-IJCP-06-214]\] to find highly expressed genes \[[@b3-IJCP-06-214], [@b4-IJCP-06-214]\], virus genes adaptation evaluation and their hostages \[[@b1-IJCP-06-214]\], indication of heterologous gene expression \[[@b5-IJCP-06-214]\], comparing organisms for codon usage favorites \[[@b1-IJCP-06-214]\], to find the genes transfection horizontally \[[@b6-IJCP-06-214], [@b8-IJCP-06-214]\] using the genomic codon for bias detection in genomes \[[@b9-IJCP-06-214]\] to study the cell cycle species \[[@b10-IJCP-06-214]\], to optimize DNA vaccines \[[@b11-IJCP-06-214]\], gene therapy \[[@b12-IJCP-06-214]\], vaccine development and recombinant therapeutics \[[@b13-IJCP-06-214]\]. Some have reported the influence of codon usage on the viral cycle among viruses. Adaptation Studies for host codon usage, have indicated viral genes which codify for critical proteins, tend to use the synonymous codons, which mostly represented in the host genome \[[@b14-IJCP-06-214] \], but the synonymous codon usage within and between genomes could not be used equally \[[@b15-IJCP-06-214]\]. Epstein-Barr Virus (EBV) is a ubiquitous double stranded DNA virus, derived of human herpes virus family, which has B-lymphotropism. More than 90% of adults have serologic evidence of infection with this virus. It has acquired during early childhood, but the age of infection is much lower in undeveloped countries with low socioeconomic condition \[[@b16-IJCP-06-214]\]. It has been documented that gastric carcinoma, Burkitt's lymphoma, undifferentiated Nasopharyngeal Carcinoma (NPC), Hodgkin's disease, B and T-cell lymphoma, and B-cell lympho proliferations among the immune compromised patients could cause by EBV \[[@b17-IJCP-06-214]-[@b20-IJCP-06-214]\]. EBV infection is ubiquitous. Iran has a high incidence rate of gastric carcinoma with an annual incidence of 26.1 per 100,000 for males and 11.1 for females \[[@b21-IJCP-06-214]\]. In bio pharmacology, researchers have interested to improve translation efficiency that is derived from protein production. Unfortunately, experiments are tedious and the reality is much more complicated. In the current study, DAMBE software (version 5.3.27) has used to assess CAI, to realize how fast EBV-GD1 could produce its proteins. These data might provide and introduce a system and principles in order to understand the pathogenesis and evolution of EBV-GD1.

Materials and Methods
=====================

The research study has started in Winter of 2012. All bioinformatics analysis has performed at bioinformatics facility of Faculty of Science in University of Zabol. Sequences of the genome segments of human herpes virus 4 strain GD1 (GenBank accession no. AY961628) have retrieved from \<http://www.ncbi.nlm.nih.gov/sites/gquery\> (GenBank accession no. AY961628) to extract all protein coding genes in order to evaluate the effectiveness of CAI from DAMBE \[[@b22-IJCP-06-214]\]. To calculate the CAI for any protein-coding sequence:
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**n** is the number of sense codons and the related **wij** value will always be 1 regardless of codon usage bias of the gene. CAI of a coding sequence (CDS) has calculated from 1) the codon frequencies of the CDS and 2) the codon frequencies of a known highly expressed genes set (often referred to as the reference set) which has been used to generate a column of **w** values:
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Where f~ij.ref~ is the frequency of codon **j** in synonymous codon family **i**, and **Maxf**~i.ref~ is the maximum codon frequency in synonymous codon family **i**. The codon whose frequency is **Maxf**~i.ref~ has been often referred to as the major codon (whose **w** is 1), and the other codons have referred as minor codons. The major codon has assumed to be the translated optimal codon.

The CAI value of a CDS has calculated as below equation:
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Where **m** is the number of synonymous codon families, **n**~i~ is the number of synonymous codons between the codon family **i**, and **f**~ij~ is the frequency of codon **j** in codon family **i**. The exponent is simply a weighted average of **ln(w)**. The maximum CAI value is 1 \[[@b23-IJCP-06-214]\]. Relative Synonymous Codon Usage (RSCU) measures codon usage bias for each codon family. It is calculated directly from input sequences. RSCU is a codon-specific index for codon usage, whereas CAI is a gene-specific index for codon usage, which related to gene expression \[[@b23-IJCP-06-214]\]. The general equation for RSCU is:
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**i** is codon family, **j** is specific codon within the family \[[@b23-IJCP-06-214]\]. For example, **i** for alanine codon family is GCU, GCC, GCA, and GCG, then **j** would be a specific codon such as GCU. RSCU measures codon usage bias for each codon family. RSCU is 1 whencodon usage bias does not exist, but RSCU would be higher than 1 when its codon is either overused or vice versa \[[@b22-IJCP-06-214]\].

Results
=======

Human herpes virus 4 strain GD1 genome segment sequences have used to evaluate the effectiveness of CAI from DAMBE. The results have shown that CAI values for the EBV-GD1 genes were 0.76356 ± 0.02957 ([Table 1](#t1-IJCP-06-214){ref-type="table"}). The highest and lowest CAI values were 0.82233 and 0.68321 respectively. The results have shown for alanine codon family (as an example), genes with high-CAI have more codon usage bias with highest RSCU being 2.923 and the lowest being only 0.246. In contrast, for the low-CAI genes, the highest and lowest RSCU is 2.797 and 0.241 ([Table 2](#t2-IJCP-06-214){ref-type="table"} and [3](#t3-IJCP-06-214){ref-type="table"}). The results have shown that highly expressed genes mostly had more codon usage bias than lowly expressed genes ([Figure 1](#f1-IJCP-06-214){ref-type="fig"}) but ANOVA for RSCU_H and RSCU_L genes , has not significantly shown difference (P\>0.05).

Discussion
==========

In molecular biology, one of the fundamental questions is genetic codes. In microorganisms, the unequal usage of synonymous codons, due to both of the mutation and the pressure of usual normal selection, has been accepted as the most common hypothesis which could effect on translation level.

The CAI has used highly expressed genes from a species to evaluate the relative merits of each codon. CAI has also used for gene expression and translation efficiency \[[@b23-IJCP-06-214]\]. The mRNA translation efficiency has depended partially on mRNA coding strategy, and has reflected codon usage bias. Codon usage bias has often determined by codon-specific, as well as the other existing gene-specific.

A representative of codon-specific could be the RSCU or relative synonymous codon usage \[[@b24-IJCP-06-214]\], and a representative of the gene-specific could be the codon adaptation index or CAI. CAI is a measure index of translation elongation rate according to our finding of highly expressed genes \[[@b25-IJCP-06-214]\]. Clarifying in a different better way, highly expressed genes would be under pressure to use abundant, or common, or cheap amino acids. On the other hand, we couldn't produce a big mass of the protein that its amino acids components would be rare or expensive. According to previous data, highly expressed genes which would use codons,have distinguished by the most abundant tRNA, in order to code each amino acid. For this matter, highly biased codon has used in highly expressed genes, especially in organisms with rapidly replication \[[@b23-IJCP-06-214]-[@b28-IJCP-06-214]\].

Finding the highly and lowly expressed genes in organisms, we might be able to select them as the main targets in pharmacology, especially in vaccine production. CAI has calculated with a reference set of highly expressed genes. The maximum CAI is 1, and the minimum is 0. In general, the higher that the CAI value would be, caused the mRNA have translatedmuch more efficient. Highly expressed human genes typically have CAI value above 0.7, have given the human reference set of highly expressed genes \[[@b23-IJCP-06-214]\]. The results have shown CAI values for the EBV-GD1 genes were 0.76356 ± 0.02957. Our result have agreed with Knipe et al. (2001) that EBV is an extremely efficient virus, which has infected a large majority of the adult population, as well as following primary infection, EBV has remained in the infected host as a lifelong asymptomatic infection \[[@b26-IJCP-06-214]\]. Xia (2007) has determined that the viruses which have caused acute diseases, as well as being pathogen, need to translate their mRNAs efficiently \[[@b27-IJCP-06-214]\].[Figure 1](#f1-IJCP-06-214){ref-type="fig"} plots the RSCU for the high-CAI genes (RSCU_H) and low-CAI genes (RSCU_L) of the 64 codons. It has shown that high-CAI genes (representing highly expressed genes) have RSCU values deviating much more from 1 than the low-CAI genes (representing lowly expressed genes) relatively. The results have shown that highly expressed genes mostly had more codon usage bias than lowly expressed genes ([Figure 1](#f1-IJCP-06-214){ref-type="fig"}) but ANOVA has not shown a significant difference (P\>0.05). This might be related to EBV, that has two different form of existence: latent and productive. The EBV genes that have been expressed during latency, has show codon usage highly different from the genes that would be expressed during lytic growth \[[@b29-IJCP-06-214]\]. For example, what could we say about the tRNA carrying alanine? From the results, GCC is the most frequently used codon, but we might predict that tRNA~Ala/AGG~ might be the most abundant. How could we test this prediction? Unfortunately this is extremely difficult experiment and all these data could be used in order to highlight the genes with high rate of expressions, related to its importance in EBV-GD1, then for this important reason might introduce a basis to understand the pathogenesis of EBV-GD1 to open a window to produce a better product or vaccine, in order to challenge with the virus.

Conclusion
----------

The results might provide and introduce a system and its principles, in order to understand the pathogenesis then evolution of EBV-GD1 and opening a window to make a better product or vaccine to challenge with the virus. Based on the results, we could find which genes or sequences would be highly expressed, or under strong natural selection to maximize translation efficiency and accuracy in order to optimize their codon usage. To say in a different way, selection should be weak for lowly expressed genes that codon usage might largely depend on mutation bias \[[@b27-IJCP-06-214]\].
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![It shows relative synonymous codon usage (RSCU) for high-CAI and low-CAI genes (RSCU_H and RSCU_L, respectively) for 64 codons of EBV-GD1.](IJCP-06-214f1){#f1-IJCP-06-214}

###### 

Output of codon adaptation index (CAI) for EBV-GD1 (Mean: 0.76356; STD: 0.02957)

  SeqName                                 SeqLen   CAI       SeqName            SeqLen   CAI
  --------------------------------------- -------- --------- ------------------ -------- ---------
  unknown\|1736                           3954     0.76709   unknown\|98764     651      0.78868
  unknown\|9710                           510      0.76776   unknown\|C99460    2427     0.78326
  unknown\|36258                          1353     0.70990   unknown\|103578    834      0.82115
  unknown\|46538                          1008     0.76740   unknown\|106768    1215     0.77914
  unknown\|47455                          1773     0.77478   unknown\|C108378   225      0.75569
  unknown\|49154                          528      0.74644   unknown\|C111572   996      0.75849
  unknown\|C49725                         9528     0.76936   probable DNA       2070     0.78928
  packaging                                                                              
  protein\|112569                                                                        
  unknown\|C59248                         3717     0.76630   unknown\|112569    975      0.76398
  unknown\|62966                          1092     0.76266   unknown\|C113494   1008     0.77171
  unknown\|64136                          2478     0.79963   unknown\|C114482   1521     0.75317
  unknown\|66629                          906      0.80136   unknown\|C115975   675      0.80152
  unknown\|67628                          1212     0.76329   unknown\|C117993   702      0.72556
  unknown\|68847                          1071     0.77103   unknown\|C118758   1260     0.75635
  unknown\|C70473                         1314     0.77520   unknown\|C120031   903      0.78173
  unknown\|C71899                         117      0.76729   unknown\|C120952   4143     0.80319
  unknown\|C71987                         2622     0.76897   unknown\|125621    1725     0.78192
  unknown\|74654                          654      0.76750   unknown\|C128546   2118     0.77372
  unknown\|C75368                         834      0.79476   unknown\|C130668   1821     0.75959
  unknown\|76277                          306      0.73176   unknown\|132490    744      0.71112
  unknown\|76655                          486      0.71418   unknown\|133046    1710     0.76698
  unknown\|C77160                         2568     0.73715   unknown\|135557    1815     0.78338
  unknown\|C77297                         444      0.72631   unknown\|C137409   744      0.75202
  unknown\|79820                          357      0.68321   unknown\|C140486   2772     0.74451
  EBNA3B (EBNA4A) latent protein\|82903   2814     0.72716   unknown\|C149527   708      0.71853
  EBNA3C latent protein\|85921            3027     0.74198   unknown\|C150198   1407     0.74320
  unknown\|C89046                         669      0.73457   unknown\|150236    309      0.72173
  Z protein\|C89811                       735      0.73358   unknown\|C151616   936      0.78017
  unknown\|C90996                         1815     0.79433   unknown\|C153152   3045     0.82233
  unknown\|92812                          930      0.77330   unknown\|C156202   2571     0.79823
  unknown\|93932                          1611     0.73806   unknown\|C160837   3384     0.80318
  unknown\|95580                          1923     0.70636   unknown\|C164308   660      0.81822
  unknown\|97588                          411      0.77062   unknown\|164957    663      0.79950
  unknown\|97983                          765      0.76167   unknown\|C166757   180      0.72802

###### 

RSCU genes with low-CAI value (RSCU_L) for EBV-GD1

  Codon   AA   ObsFreq   RSCU_L   Codon   AA   ObsFreq   RSCU_L
  ------- ---- --------- -------- ------- ---- --------- --------
  UAG     \*   0         0.000    UGA     \*   1         1.000
  GCU     A    12        0.361    UAA     \*   2         2.000
  GCC     A    20        0.602    GCG     A    8         0.241
  UGU     C    3         0.750    GCA     A    93        2.797
  GAU     D    34        1.172    UGC     C    5         1.250
  GAG     E    21        0.792    GAC     D    24        0.828
  UUU     F    13        1.444    GAA     E    32        1.208
  GGU     G    29        0.410    UUC     F    5         0.556
  GGC     G    29        0.410    GGG     G    76        1.074
  CAC     H    5         0.455    GGA     G    149       2.106
  AUU     I    17        1.821    CAU     H    17        1.545
  AUC     I    6         0.643    AUA     I    5         0.536
  AAG     K    17        1.478    AAA     K    6         0.522
  CUC     L    14        1.167    CUA     L    14        1.167
  CUU     L    13        1.083    CUG     L    7         0.583
  UUG     L    8         1.000    UUA     L    8         1.000
  AAC     N    12        1.143    AUG     M    20        1.000
  CCA     P    68        1.744    AAU     N    9         0.857
  CCU     P    40        1.026    CCC     P    33        0.846
  CAA     Q    28        1.217    CCG     P    15        0.385
  AGA     R    19        0.844    CAG     Q    18        0.783
  CGA     R    10        1.000    AGG     R    26        1.156
  CGG     R    12        1.200    CGC     R    9         0.900
  AGC     S    11        0.759    CGU     R    9         0.900
  UCA     S    24        2.043    AGU     S    18        1.241
  UCG     S    4         0.340    UCC     S    11        0.936
  ACC     T    14        1.167    UCU     S    8         0.681
  ACG     T    7         0.583    ACA     T    17        1.417
  GUU     V    10        0.930    ACU     T    10        0.833
  GUC     V    12        1.116    GUG     V    11        1.023
  UGG     W    12        1.000    GUA     V    10        0.930
  UAU     Y    10        1.429    UAC     Y    4         0.571

ObsFreq: observation frequency; AA: amino acid. RSCU_L: Low relative synonymous codon usage.

###### 

RSCU genes with high-CAI value (RSCU_H) for EBV-GD1

  Codon   AA   ObsFreq   RSCU\_ H   Codon   AA   ObsFreq   RSCU\_ H
  ------- ---- --------- ---------- ------- ---- --------- ----------
  UAG     \*   1         1.000      UGA     \*   0         0.000
  GCU     A    8         0.246      UAA     \*   2         2.000
  GCC     A    95        2.923      GCG     A    18        0.554
  UGU     C    8         0.390      GCA     A    9         0.277
  GAU     D    22        0.518      UGC     C    33        1.610
  GAG     E    70        1.750      GAC     D    63        1.482
  UUU     F    33        0.971      GAA     E    10        0.250
  GGU     G    3         0.132      UUC     F    35        1.029
  GGC     G    41        1.802      GGG     G    39        1.714
  CAC     H    31        1.442      GGA     G    8         0.352
  AUU     I    15        0.703      CAU     H    12        0.558
  AUC     I    40        1.875      AUA     I    9         0.422
  AAG     K    63        1.703      AAA     K    11        0.297
  CUC     L    58        1.415      CUA     L    9         0.220
  CUU     L    4         0.098      CUG     L    93        2.268
  UUG     L    10        1.818      UUA     L    1         0.182
  AAC     N    37        1.609      AUG     M    29        1.000
  CCA     P    15        0.779      AAU     N    9         0.391
  CCU     P    14        0.727      CCC     P    36        1.870
  CAA     Q    10        0.417      CCG     P    12        0.623
  AGA     R    9         0.529      CAG     Q    38        1.583
  CGA     R    4         0.219      AGG     R    25        1.471
  CGG     R    29        1.589      CGC     R    34        1.863
  AGC     S    27        1.636      CGU     R    6         0.329
  UCA     S    7         0.444      AGU     S    6         0.364
  UCG     S    16        1.016      UCC     S    31        1.968
  ACC     T    35        1.892      UCU     S    9         0.571
  ACG     T    25        1.351      ACA     T    12        0.649
  GUU     V    4         0.143      ACU     T    2         0.108
  GUC     V    37        1.321      GUG     V    66        2.357
  UGG     W    15        1.000      GUA     V    5         0.179
  UAU     Y    11        0.379      UAC     Y    47        1.621

ObsFreq: observation frequency; AA: amino acid. RSCU_H: High relative synonymous codon usage.
